期刊文献+

聚电解质复合法载表阿霉素纳米微粒的制备及抗胰腺癌作用的研究 被引量:2

聚电解质复合法载表阿霉素纳米微粒的制备及抗胰腺癌作用的研究
下载PDF
导出
摘要 目的合成载表阿霉素纳米微粒(E-ADM-NPs)并检测其相关参数,观察其对人胰腺癌细胞的杀伤作用。方法采用聚电解质复合法合成E-ADM-NPs,动态光散射粒子分析仪测定粒径,分光光度法计算包封率,噻唑蓝(MTT)法观察对胰腺癌细胞的体外杀伤作用。结果E-ADM-NPs的平均粒径(185±23)nm,包封率(76.2±6.5)%,体内抑瘤实验表明E-ADM-NPs的疗效优于未包载表阿霉素(unenveloped epirubicin,E-ADM)。 Objective To prepare E-ADM-NPs. detect their correlative parameters and explore their anti-pancreatic carcinoma effect. Methods The E-ADM-NPs were prepared by the method of polyelectrolyte complexation. The diameter of the nanoparticles was determined by dynamic light scattering particle analysator. The embedding ratio of E-ADM-NPs was calculated by spectrophotometer. The inhibitory effect of the particles on pancreatic carcinoma cells was explored by MTT assay in vitro. Results The mean diameter of E-ADM-NPs was (185-23)nm, the embedding ratio was (76.2±6.5)%. The in vivo tests manifested that the efficacy of E-ADM-NPs had advantages over E-ADM. Conclusion As a novel and safe kind of drug sustained release system, E-ADM-NPs can effectively inhibit the growth of pancreatic carcinoma cells.
出处 《当代医学》 2009年第33期1-2,共2页 Contemporary Medicine
基金 广东省医学科研基金(B2007173)
关键词 聚电解质复合法 表阿霉素 胰腺癌 纳米 缓释 Polyelectrolyte complexation Epirubicin Pancreatic carcinoma Nanoparticle Sustained release
  • 相关文献

参考文献2

二级参考文献20

  • 1刘秀洞.膜乳化法制备壳聚糖/海藻酸微胶囊.第九届全国生物化工学术会议论文集[M].-,2000.475-477.
  • 2[7]HEIATA H RASHAD T,RICHARD R S, et al. Solid lipid nanoparticles as drug carriers I Incorporation and retention of the lipophilie prodrug 3'-azido-3 '-deoxythymidine palmutate[J].Int J Pharm. 1997, 146(1): 123.
  • 3[8]MULLER R H,DORTE R,STEPHAN A R.Bioegradation of solid lipid nanoparticles as afunction of lipase incubation time[J].Int J Pharm. 1996,144(11):115.
  • 4[9]HODOSHIMA N,UDAGAWA C,ANDO H,et al. Lipid nahoparticles for delivering antitumor drugs[J]. Int J Pharm. 1997.146.138(1):81.
  • 5[10]ROBERTA C,OTTO C MARIA E C,et al. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles[J]. Int J Pharm, 1997,148(1):47.
  • 6[11]ILLUM L,DAVIS S S.Targeting of coiioidal particles to the bone marrow[J].Life Sci, 1987,40:1553.
  • 7[12]ILLUM L,DAVIS S S, MULLER R H. The oegan distribution and circulation time of muavenously injected colloidal carriers sterically stabilized with a block copolymer-poloxamine908[J] .Life Sci, 1987,40:367.
  • 8[13]TAN S et al Surface modification of nanoparticles byPEO/PPO block copolymers to minimize interaction with blood component sand prolong blood circulation in rars[J]. biomaterials, 1993, 14(11):823.
  • 9[14]Tro ster, et al Modification of the body distribution of poly(methylmethacrylates) nanoparticles in rats by coating with surfactants [J].int J pharm, 1990.61,85.
  • 10陈兰英.多种维生素静脉注射液的研制[J].药学通报,1982,(7):794.

共引文献44

同被引文献19

  • 1Ramirez J,Duffort D, Obispo TM, et al. Group 5 determination in Pooideae grass pollen extracts by monoclonal antibody-based ELISA. Correlation with biologic activity[J]. Allergy, 1997, 52 (8) : 806-813.
  • 2Wu J,Nantz MH,Zern MA. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications [J]. Front Biosci, 2002,7 : 717-725.
  • 3Ramirez ], Obispo TM, Duffort D, et al. Group 5 determination in Pooideae grass pollen extracts by monoclonal antibody-based ELISA [J]. Correlation with biologic activity Allergy, 1997,52 (8) : 806-813.
  • 4KoUermann J, Helpap B. Expression of vascular endothelial growth factor (VEGF) and' VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue [J]. Am J Clin Pathol,2001,116 (1): t15-121.
  • 5Klement G,Baruehel S,Rak J,et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity[J]. J Clin Invest,2000,105 (8) : 15-24.
  • 6Ran S, Huang X,Downes A,et al. Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenie or vascular targeting agents for tumor therapy [J]. Neoplasia,2003,5(4) :297-307.
  • 7撒忠秋,倪雷,秦建民.纳米粒在肝癌靶向治疗中的研究进展[J].肝胆外科杂志,2010,18(2):145-147. 被引量:2
  • 8孙沂,樊宏伟,王书奎,张振玉.阿司匹林、氯吡格雷联用对人胃黏膜上皮细胞株GES-1增殖的影响[J].胃肠病学和肝病学杂志,2010,19(6):520-523. 被引量:9
  • 9忻志鸣,叶根深.纳米粒制剂研究进展[J].中国药业,2010,19(16):15-17. 被引量:26
  • 10蔡应娱,李伟毅.血管内皮生长因子(VEGF)的生物活性及其在临床中的应用[J].细胞与分子免疫学杂志,2010,26(11):1164-1166. 被引量:9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部